Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in Refractory Germ Cell Tumors Expressing EGFR
NCT00198159Phase 2Terminated
- Sponsor
- Indiana University School of Medicine
- Start
- Sep 2002
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in germ cell tumor (GCT), sponsored by Indiana University School of Medicine. Started Sep 2002; status: terminated.
02
Drugs
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00198159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198159.